|
|
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and
regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.
( Total: 10 Current Stock Recommendations )
|
|
|
|
|
|
|
|
|
|
* As of 5/17/2013 12:00 AM
|
|
|
|
|